[stock_market_widget type="clock-markets" template="analog" timezone="America/New_York" title="New York" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/London" title="London" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Europe/Brussels" title="Brussels" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Hong_Kong" title="Hong Kong" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Asia/Tokyo" title="Tokyo" style="font-size: 7px; width: 100px;"] [stock_market_widget type="clock-markets" template="analog" timezone="Australia/Sydney" title="Sydney" style="font-size: 7px; width: 100px;"]

Stock Market News

OKYO Pharma IPO Opens 13% Higher

05/17/2022

Less than a minute

2022.05.17 18:26

OKYO Pharma IPO Opens 13% Higher
OKYO Pharma (OKYO) IPO Opens 13% Higher

Today’s IPO for OKYO Pharma Limited (Nasdaq: OKYO) opened for trading at $4.50 per ADS after pricing 625,000 ADSs (representing 40,625,000 new ordinary shares of no par value) at a price of $4.00 per ADS.

ThinkEquity LLC was the sole bookrunning manager for the IPO.

OKYO Pharma is a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain.

Source

05/17/2022

Less than a minute